Literature DB >> 3371722

Pathophysiological study of diarrhoea in a patient with medullary thyroid carcinoma. Evidence against a secretory mechanism and for the role of shortened colonic transit time.

J C Rambaud1, R Jian, B Flourié, M Hautefeuille, M Salmeron, F Thuillier, A Ruskoné, C Florent, F Chaoui, J J Bernier.   

Abstract

Intubation techniques and scintigraphic studies were used to determine the origin and mechanism of diarrhoea in a patient with medullary thyroid carcinoma, high plasma immunoreactive calcitonin and normal circulating serotonin, substance P and prostaglandins E2 and F2 alpha. Normal function of the small intestine was found for the following: (a) absorption tests; (b) water and electrolyte absorption in the proximal jejunum; (c) 24 hour flow rate and composition of fluid entering the colon and (d) gastric emptying rate and small intestinal progression of a normal meal. By contrast, colonic function was markedly impaired in three ways: (a) water absorption was decreased by half; (b) as the main excreted solutes were organic acids, a large electrolyte gap was recorded in faecal water, and (c) colonic transit time of the meal marker was very short, and was in agreement with the rapid transit of ingested radioopaque markers. These data strongly suggest that decreased absorption in the colon secondary to a motor disturbance is the main mechanism of diarrhoea in this case of medullary thyroid carcinoma, while calcitonin induced small intestinal fluid secretion suggested earlier is either non-existent, or only of minor importance.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3371722      PMCID: PMC1433550          DOI: 10.1136/gut.29.4.537

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  27 in total

1.  Prostaglandin secretion by medullary carcinoma of the thyroid. A possible cause of the associated idarrhoea.

Authors:  E D Williams; S M Karim; M Sandler
Journal:  Lancet       Date:  1968-01-06       Impact factor: 79.321

2.  [Intestinal absorption of sodium and potassium studied with intestinal perfusion of isotonic solutions in man].

Authors:  J C Rambaud; C Thiry; J J Bernier
Journal:  Acta Gastroenterol Belg       Date:  1973 Jan-Feb       Impact factor: 1.316

3.  Diarrhea and medullary carcinoma of the thyroid.

Authors:  C M Steinfeld; C G Moertel; L B Woolner
Journal:  Cancer       Date:  1973-05       Impact factor: 6.860

4.  [Effects of glucose on net and unidirectional movements of water and electrolytes in the human small intestine].

Authors:  R Modigliani; J J Bernier
Journal:  Biol Gastroenterol (Paris)       Date:  1972

5.  In vivo dialysis of faeces as a method of stool analysis. IV. The organic anion component.

Authors:  R Rubinstein; A V Howard; O M Wrong
Journal:  Clin Sci       Date:  1969-10       Impact factor: 6.124

6.  Intestinal ganglioneuromatosis, diarrhoea and medullary thyroid carcinoma.

Authors:  T Normann; B Otnes
Journal:  Scand J Gastroenterol       Date:  1969       Impact factor: 2.423

7.  A biological assay for calcitonin.

Authors:  M A Kumar; E Slack; A Edwards; H A Soliman; A Baghdiantz; G V Foster; I MacIntyre
Journal:  J Endocrinol       Date:  1965-11       Impact factor: 4.286

8.  Water and electrolyte transport during maintenance of isotonicity in human jejunum and ileum.

Authors:  S F Phillips; W H Summerskill
Journal:  J Lab Clin Med       Date:  1967-10

9.  Diarrhoea associated with medullary carcinoma of the thyroid.

Authors:  J J Bernier; J C Rambaud; D Cattan; A Prost
Journal:  Gut       Date:  1969-12       Impact factor: 23.059

10.  Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients.

Authors:  M F Saad; N G Ordonez; R K Rashid; J J Guido; C S Hill; R C Hickey; N A Samaan
Journal:  Medicine (Baltimore)       Date:  1984-11       Impact factor: 1.889

View more
  9 in total

Review 1.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

Review 2.  Multiple endocrine neoplasia.

Authors:  R A Decker; S A Wells
Journal:  Jpn J Surg       Date:  1989-11

3.  2012 European thyroid association guidelines for metastatic medullary thyroid cancer.

Authors:  M Schlumberger; L Bastholt; H Dralle; B Jarzab; F Pacini; J W A Smit
Journal:  Eur Thyroid J       Date:  2012-03-28

4.  Efficacy of the Natural Clay, Calcium Aluminosilicate Anti-Diarrheal, in Reducing Medullary Thyroid Cancer-Related Diarrhea and Its Effects on Quality of Life: A Pilot Study.

Authors:  Ramona Dadu; Mimi I Hu; Charles Cleeland; Naifa L Busaidy; Mouhammed Habra; Steven G Waguespack; Steven I Sherman; Anita Ying; Patricia Fox; Maria E Cabanillas
Journal:  Thyroid       Date:  2015-08-20       Impact factor: 6.568

5.  A calcitonin and vasoactive intestinal peptide-producing pancreatic endocrine tumor associated with the WDHA syndrome.

Authors:  Tatsunosuke Ichimura; Satoshi Kondo; Shunichi Okushiba; Toshiaki Morikawa; Hiroyuki Katoh
Journal:  Int J Gastrointest Cancer       Date:  2003

6.  Calcitonin receptor-mediated CFTR activation in human intestinal epithelial cells.

Authors:  Hongguang Liu; Amika Singla; Mei Ao; Ravinder K Gill; Jayashree Venkatasubramanian; Mrinalini C Rao; Waddah A Alrefai; Pradeep K Dudeja
Journal:  J Cell Mol Med       Date:  2011-12       Impact factor: 5.310

Review 7.  Metastatic medullary thyroid carcinoma: a new way forward.

Authors:  Anna Angelousi; Aimee R Hayes; Eleftherios Chatzellis; Gregory A Kaltsas; Ashley B Grossman
Journal:  Endocr Relat Cancer       Date:  2022-05-31       Impact factor: 5.900

Review 8.  Vandetanib: opening a new treatment practice in advanced medullary thyroid carcinoma.

Authors:  Cosimo Durante; Alessandra Paciaroni; Katia Plasmati; Fabiana Trulli; Sebastiano Filetti
Journal:  Endocrine       Date:  2013-04-14       Impact factor: 3.633

9.  Endocrine paraneoplastic syndromes in patients with neuroendocrine neoplasms.

Authors:  Kosmas Daskalakis; Eleftherios Chatzelis; Marina Tsoli; Nektaria Papadopoulou-Marketou; Georgios K Dimitriadis; Apostolos V Tsolakis; Gregory Kaltsas
Journal:  Endocrine       Date:  2018-10-02       Impact factor: 3.633

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.